Paragon Bioservices

Paragon Bioservices

Biotechnology, 801 W Baltimore St, Baltimore, Maryland, 21201, United States, 10001+ Employees

paragonbioservices.com

  • facebook
  • LinkedIn

phone no Phone Number: 21********

Who is PARAGON BIOSERVICES

With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T imm...

Read More

map
  • 801 W Baltimore St, Baltimore, Maryland, 21201, United States Headquarters: 801 W Baltimore St, Baltimore, Maryland, 21201, United States
  • 1990 Date Founded: 1990
  • 10001+ Employees: 10001+
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PARAGON BIOSERVICES

Paragon Bioservices Org Chart and Mapping

Employees

Terrence Reilly

Manufacturing Technician

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Paragon Bioservices

Answer: Paragon Bioservices's headquarters are located at 801 W Baltimore St, Baltimore, Maryland, 21201, United States

Answer: Paragon Bioservices's phone number is 21********

Answer: Paragon Bioservices's official website is https://paragonbioservices.com

Answer: Paragon Bioservices's revenue is $100 Million to $250 Million

Answer: Paragon Bioservices's SIC: 2836

Answer: Paragon Bioservices's NAICS: 541714

Answer: Paragon Bioservices has 10001+ employees

Answer: Paragon Bioservices is in Biotechnology

Answer: Paragon Bioservices contact info: Phone number: 21******** Website: https://paragonbioservices.com

Answer: With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access